Since pharmaceutical companies Pfizer and Valneva announced positive results from their phase 3 trial of a vaccine to prevent Lyme disease last month, two questions have loomed large: Will the vaccine ...
The charter, published on Thursday, alters the makeup and purpose of the panel, opening the door for Health Secretary Robert F. Kennedy Jr. to reclaim his revision of national vaccine policy. By ...
Public health institutions are under threat by populist governments across the globe. Doctors and scientists across the country worry about long-term damage to the country’s health system. As a ...
The plummeting demand for Merck & Co.’s HPV vaccine Gardasil in China has forced the New Jersey drugmaker to rework its arrangement with its partner in the country, Chongqing Zhifei Biological ...
This week, Pfizer and French vaccine company, Valneva, released phase 3 clinical trial data for PF-0730740, a four-dose Lyme disease vaccine they developed together that is about 70% effective. While ...
If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the ...
Add Yahoo as a preferred source to see more of our stories on Google. Image: Spencerbdavis - Wikimedia Commons Three state legislatures are pushing bills to classify COVID mRNA vaccines as “weapons of ...
Pfizer and Valenva are seeking regulatory approval from the Food and Drug Administration for a Lyme disease vaccine in development that's more than 70% effective against the tick-borne illness.
A Lyme disease vaccine produced by Pfizer and Valneva was deemed 70 percent effective by the companies after they reviewed the results from a phase 3 trial. If approved by regulators, it would be the ...
Pfizer and Valneva said Monday their Lyme disease vaccine showed more than 70% efficacy in a late-stage study, even as it missed its main goal. Subscribe to read this story ad-free Get unlimited ...
The future of the US Centers for Disease Control and Prevention’s panel of vaccine advisers is unclear, even among its recently appointed members. On Monday, a federal judge temporarily blocked the US ...
On Monday, a federal judge issued a preliminary ruling with a harsh reprimand for the Trump administration: You’ve done this vaccine stuff all wrong. The Trump administration likely broke the law, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results